SCHEMBL13699690

SCHEMBL13699690

CCOc1ccc2c(N)c(C(N)=O)oc2c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 11/20 0.51
HPGD P15428 7/20 0.48
TP53 P04637 2/20 0.48
LMNA P02545 1/20 0.48
MAPT P10636 1/20 0.48
ALOX15 P16050 1/20 0.48
MAPK10 P53779 1/20 0.48
ALDH1A1 P00352 7/20 0.48
GAA P10253 1/20 0.48
AHR P35869 1/20 0.47
HSD17B10 Q99714 3/20 0.47
PARP10 Q53GL7 1/20 0.46
CYP1A2 P05177 3/20 0.44
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA4 P22748 1/20 0.44
CA6 P23280 1/20 0.44
CA5A P35218 1/20 0.44
CA7 P43166 1/20 0.44
CA9 Q16790 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13699674 0.84 KDM4E (0.59) KDM4EHPGDTP53LMNAMAPT
SCHEMBL13699677 0.82 MAOB (0.56) PARP10RAB9ANPC1
SCHEMBL13699683 0.78 KDM4E (0.50) KDM4EHPGDTP53LMNAMAPT
SCHEMBL8115968 0.78 SLC2A1 (0.60) KDM4EHPGDTP53MAPTALDH1A1
SCHEMBL20534963 0.77 KDM4E (0.52) KDM4EHPGDTP53LMNAMAPT
SCHEMBL13699685 0.76 KDM4E (0.54) KDM4EHPGDTP53MAPTALOX15
SCHEMBL13699678 0.75 ALDH1A1 (0.53) KDM4EHPGDTP53LMNAMAPT
SCHEMBL8437810 0.74 KDM4E (0.62) KDM4EALDH1A1AHRRAB9ANPC1
SCHEMBL13700042 0.74 MAPT (0.58) HPGDTP53LMNAMAPTALOX15
SCHEMBL13699669 0.73 KDM4E (0.54) KDM4EHPGDTP53MAPTMAPK10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE KISSEI PHARMACEUTICAL CO., LTD. (JP) 2009-09-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE ADORA2A, ADORA2B, HTR1F KDM4E 4227/4885HPGD 3251/4885TP53 4721/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.